LifePro Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$397K Sell
2,451
-1,126
-31% -$179K 0.24% 93
2024
Q2
$523K Buy
3,577
+91
+3% +$13.5K 0.37% 61
2024
Q1
$551K Sell
3,486
-202
-5% -$32.2K 0.36% 64
2023
Q4
$578K Sell
3,688
-52
-1% -$7.97K 0.45% 53
2023
Q3
$582K Sell
3,740
-4,779
-56% -$789K 0.48% 50
2023
Q2
$1.41M Buy
8,519
+4,372
+105% +$706K 1.09% 32
2023
Q1
$733K Hold
4,147
0.53% 43
2022
Q4
$733K Buy
4,147
+54
+1% +$9.32K 0.54% 42
2022
Q3
$669K Sell
4,093
-685
-14% -$116K 0.38% 29
2022
Q2
$848K Sell
4,778
-39
-0.8% -$6.95K 0.44% 46
2022
Q1
$854K Sell
4,817
-705
-13% -$120K 0.31% 47
2021
Q4
$945K Buy
5,522
+951
+21% +$156K 0.28% 42
2021
Q3
$738K Buy
4,571
+121
+3% +$20.6K 0.22% 41
2021
Q2
$733K Buy
4,450
+6
+0.1% +$993 0.22% 36
2021
Q1
$730K Sell
4,444
-145
-3% -$23.5K 0.23% 36
2020
Q4
$722K Buy
+4,589
New +$677K 0.22% 39

Other funds holding JNJ

LifePro Asset Management's JNJ Position: Q3 2024 in Review

LifePro Asset Management reduced its Johnson & Johnson (JNJ) stake by 31% in Q3 2024, selling an estimated $179K and leaving 2,451 shares worth $397K. The position accounts for 0.24% of the portfolio, ranked #93.

LifePro Asset Management first reported a position in JNJ in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.41M in Q2 2023. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • LifePro Asset Management held 2,451 shares of Johnson & Johnson worth $397K as of Q3 2024.
  • LifePro Asset Management sold 1,126 Johnson & Johnson shares in Q3 2024, an estimated $179K.
  • Johnson & Johnson made up 0.24% of LifePro Asset Management's portfolio in Q3 2024, its #93 holding.
  • LifePro Asset Management first reported a position in Johnson & Johnson in Q4 2020 and has held it in 16 quarters since.
  • LifePro Asset Management's Johnson & Johnson position peaked at $1.41M in Q2 2023.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.